Decreased plasma IL-35 levels are related to the left ventricular ejection fraction in coronary artery diseases.
about
Interleukin-35: Expanding Its Job ProfileThe modulation of endoplasmic reticulum stress by chemical chaperone upregulates immune negative cytokine IL-35 in apolipoprotein E-deficient miceMathematical modeling of Interleukin-35 promoting tumor growth and angiogenesisIncreased plasma concentrations of interleukin 35 in patients with coronary artery disease.Preclinical development of AMG 139, a human antibody specifically targeting IL-23Elevated Plasma IL-38 Concentrations in Patients with Acute ST-Segment Elevation Myocardial Infarction and Their Dynamics after Reperfusion Treatment.Mucosal Administration of Collagen V Ameliorates the Atherosclerotic Plaque Burden by Inducing Interleukin 35-dependent Tolerance.Elevated serum IL-35 and increased expression of IL-35-p35 or -EBI3 in CD4(+)CD25(+) T cells in patients with active tuberculosis.IL-35 improves Treg-mediated immune suppression in atherosclerotic miceElevated plasma IL-37, IL-18, and IL-18BP concentrations in patients with acute coronary syndrome.Interleukin 35 Polymorphisms Are Associated with Decreased Risk of Premature Coronary Artery Disease, Metabolic Parameters, and IL-35 Levels: The Genetics of Atherosclerotic Disease (GEA) Study.Interleukin 35: a key mediator of suppression and the propagation of infectious tolerance.Treating atherosclerosis with regulatory T cells.IL-35: a potential therapeutic target for controlling hepatitis B virus infection.Interluekin-35 in Asthma and Its Potential as an Effective Therapeutic Agent.IL-35, as a newly proposed homeostasis-associated molecular pattern, plays three major functions including anti-inflammatory initiator, effector, and blocker in cardiovascular diseases.Interleukin-35 on B cell and T cell induction and regulation.Plasma interleukin-27 levels in patients with coronary artery disease.Interleukin 27 is increased in carotid atherosclerosis and promotes NLRP3 inflammasome activation.Elevated serum IL-39 in patients with ST-segment elevation myocardial infarction was related with left ventricular systolic dysfunction.Regulatory T cells as a new therapeutic target for atherosclerosis.The Role, Involvement and Function(s) of Interleukin-35 and Interleukin-37 in Disease Pathogenesis.
P2860
Q26829619-76F9A4DA-B673-498E-BBBC-DBBFD0832DE4Q28539349-1B4E5424-C515-4769-B1D7-B7AB1896C017Q28544606-7C3BC226-AA02-4AA7-A515-E488D431BC1EQ33904487-74B93D30-ECD5-415B-A02F-D66148047FBCQ34795742-FF9D7A70-6DAC-4114-AD91-7CB0091A9988Q36447221-7F3CD802-10C2-4AAA-8C74-58A6859FC685Q36573968-CC47C274-DEB5-4B42-A987-36CD8784744AQ36841195-0BA89889-0961-4317-B416-AB11189B8B4DQ37289372-7621B268-E339-42AD-9F7A-23A45CDAE7A7Q37661552-5B6CEAF2-5263-47EA-BF55-35A659AA8E37Q37685707-41483DD2-1D53-4949-8389-136D8B8B2601Q38154886-D25EE39D-7CE8-41F2-9104-A025059B482DQ38270134-2F8EE734-BDF2-40B8-9CFF-CF3BCB859B6EQ38283391-91437E7B-BDEF-4476-A523-C2A2FCEB5326Q39335458-0472BC7C-79A7-4CED-B16E-EDA6F5A1267DQ39396961-B3E2ACE2-7675-45F4-9163-1B2DA33623C8Q41292130-2543942B-DB44-470D-B6E6-11B06828D2B2Q46938854-AE0D76B3-15F7-4C52-9A92-99879F49223EQ47363732-651E3469-F45F-4EB2-8824-6CD15FA021EFQ48229534-734B243F-FCC1-4223-8B53-E6724202AFE1Q50093330-565C7B12-BC53-4315-A232-6D7B14E8A352Q52594247-BCB3D26E-300A-4A8E-ACF2-C293C7E62E85
P2860
Decreased plasma IL-35 levels are related to the left ventricular ejection fraction in coronary artery diseases.
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Decreased plasma IL-35 levels ...... n in coronary artery diseases.
@ast
Decreased plasma IL-35 levels ...... n in coronary artery diseases.
@en
Decreased plasma IL-35 levels ...... n in coronary artery diseases.
@nl
type
label
Decreased plasma IL-35 levels ...... n in coronary artery diseases.
@ast
Decreased plasma IL-35 levels ...... n in coronary artery diseases.
@en
Decreased plasma IL-35 levels ...... n in coronary artery diseases.
@nl
prefLabel
Decreased plasma IL-35 levels ...... n in coronary artery diseases.
@ast
Decreased plasma IL-35 levels ...... n in coronary artery diseases.
@en
Decreased plasma IL-35 levels ...... n in coronary artery diseases.
@nl
P2093
P2860
P1433
P1476
Decreased plasma IL-35 levels ...... n in coronary artery diseases.
@en
P2093
Qingwei Ji
Qiutang Zeng
Xiaoyan Wang
Yifeng Cao
Ying Huang
Yingzhong Lin
Zhengde Lu
P2860
P304
P356
10.1371/JOURNAL.PONE.0052490
P407
P577
2012-12-21T00:00:00Z